← Back to all trials
Completed
NCT07861477
Murottal as Adjunctive Intervention in Pediatric
Conditions: Pediatric Cancer, Hematologic Malignancies, Anxiety, Sleep Disturbances in Children, Leukemia (Both ALL and AML)
Sex: All
Ages: 8 Years – 12 Years
Healthy volunteers: No
Phase: NA
Enrollment: 20
Sponsor: Universitas Airlangga
Location: Dr. Soetomo Public Hospital Surabaya East Java
Summary
This study aims to evaluate whether listening to the recitation of Surah Ar-Rahman (Murottal) before bedtime can help improve anxiety and sleep quality in hospitalized children with blood cancer. Twenty children aged 8-12 years will be divided into two groups: one group will receive standard care plus the Murottal intervention for 7 days, while the other group will receive standard care only. Anxiety and sleep quality will be measured using validated questionnaires (SCARED and SDSC) before and after the intervention. We hope this study will provide evidence that Murottal can be a safe, non-invasive, and culturally appropriate supportive therapy for pediatric cancer patients.
Eligibility Criteria
Inclusion Criteria:
* Participants were Muslim pediatric patients aged 8-12 years diagnosed with hematological malignancies (acute lymphoblastic leukemia, acute myeloid leukemia, or chronic myelogenous leukemia) and hospitalized for chemotherapy. Inclusion required preserved auditory function, Indonesian-literate guardians and baseline anxiety (SCARED score ≥25) or sleep disturbance (SDSC score \>39).
Exclusion Criteria:
* Subjects were excluded if they had severe neurological disorders, medical instability, ICU care, or undetected sensory or auditory impairments at baseline. Participants who withdrew consent or had significant medical deterioration or complications requiring transfer to the pediatric ICU, and those who did not complete at least 5 of 7 intervention sessions were excluded from analysis.
Source: ClinicalTrials.gov (NCT07861477). StuddyBuddy aggregates publicly available trial information.